Community Acquired Pneumonia Guidelines

December 05, 2017

Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.

Osteoporosis Treatments

November 30, 2017

Osteoporosis treatment and prevention doses including recommended calcium and vitamin D supplemental doses.

Most Multi-Med Patients Have Not Discussed Possible Drug Interactions

November 30, 2017

In terms of who is responsible for talking to patients about possible drug interactions, 11, 26, and 63% felt that the pharmacist, doctor, and both doctor and pharmacist are responsible, respectively.

New Study Sheds Light on Safety of Gadolinium-Based Contrast Agents

By November 29, 2017

After adjusting for gender, age, education level, baseline neurocognitive performance, and others, the authors reported gadolinium exposure was not a significant predictor of cognitive decline, dementia, diminished neuropsychological performance or diminished motor performance

Steroid Injection Site Linked to Bone Changes in Osteoarthritis Patients

By November 29, 2017

Their results found that 22-24% of the hip injection group had new osteonecrosis vs. 5-9% of the hip control group and to 5% of the shoulder injection group.

Drug-Induced Dry Mouth Common Among Seniors Taking Certain Meds

By October 30, 2017

There are a number of medications that are linked to dry mouth.

ACIP: New Vaccine Recommendations for Shingles Prevention

By October 25, 2017

The Committee voted that Shingrix is preferred over Zostavax for the prevention of zoster and related complications.

FDA Approves Shingrix for Prevention of Shingles

By October 23, 2017

The use of Shingrix also decreased the overall incidence of postherpetic neuralgia (PHN).

Glaucoma Treatments

October 13, 2017

Glaucoma treatment chart (alpha2-agonists, beta blockers, carbonic anhydrase inhibitors, cholinergic agonists, prostaglandin analogs).

Intervention Technique Shows Promise for Discontinuing Inappropriate Meds

October 10, 2017

Researchers examined discontinuation of inappropriate medication use among nursing home residents in a cluster randomized controlled trial conducted in 59 Dutch nursing home wards.

Older Patients Often Use Rx and OTC Meds to Help with Sleep

By September 27, 2017

Overall among each medication type (prescription, over-the-counter and herbal/natural aids) 36% reported using some type of medication to aid their sleep.

USPSTF Issues New Fall Prevention Recommendations

September 27, 2017

Multifactorial interventions to prevent falls should be offered selectively by clinicians; the overall net benefit of routinely offering multifactorial interventions is small.

Study Assesses Awareness of 'Deprescribing' Among Older Patients

September 22, 2017

Researchers found that nearly half (48%) had researched medication-related harms either through the internet (35.5%) or from health care professionals (32.2%). However, only 6.9% recognized the term deprescribing.

Increased Med Use Over Time Seen in Older Patients of All BMI Classes

By September 22, 2017

Researchers aimed to determine whether the rise in prescription drug use over time varied by age and obesity status.

Beta-Blocker Use Post-Heart Attack Called Into Question

By September 19, 2017

They found that patients who only took the ACE inhibitor, or an angiotensin receptor blocker, and statin were no more likely to die than those who took all 3 prescribed treatments.

Daily Consumption of 'Cancer Preventative' Leads to Cyanide Poisoning

By September 13, 2017

The patient admitted to taking 2 teaspoons of self-prepared apricot kernel extract along with 3 tablets of Novodalin, an herbal fruit kernel supplement, every day for the past 5 years.

Alendronate Safe, Effective in Elderly Patients with Prior Fracture

September 07, 2017

Alendronate treatment reduced risk of hip fracture with sustained safety

Test Predicts Elderly Patients' Ability to Learn Insulin Self-Injection Technique

September 05, 2017

Number of animal names recalled in one minute was the most useful indicator

Thromboembolic Disorder Assessment: DVT/PE

September 04, 2017

Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).

Limiting Sedentary Time 'Necessary' to Avoid Mobility Loss

August 31, 2017

At the study's end, 29% of participants were either unable to walk or had difficulty doing so.

High Systolic BP Linked to Negative Cognitive Outcomes

August 23, 2017

Researchers find that healthy reductions may benefit blacks even more than whites

Lithium, Divalproex Efficacy Examined in Older Bipolar Patients

By August 09, 2017

Results demonstrated that lithium was more effective in controlling manic signs and symptoms, as defined by a change from baseline Young Mania Rating Scale.

Does Aspirin Protect Against Symptoms of Depression?

By August 08, 2017

Research on whether aspirin (which has both anti-inflammatory and anti-atherosclerotic properties) has an impact on depression has been limited.

Parkinsonism Treatments

July 28, 2017

Parkinson's drug treatment chart categorized by pharmacological class.

Neuropathic Pain Treatments

July 27, 2017

Chart with medications used to treat neuropathic pain, including diabetic peripheral neuropathy, fibromyalgia, and postherpetic neuralgia.

Recombinant Flu Vaccine May Protect Seniors Better than Traditional Vaccine

By June 22, 2017

Flublok Quadrivalent, approved by the Food and Drug Administration (FDA) in October 2016, is a recombinant protein-based vaccine developed without the use of eggs.

Do PPIs Increase the Risk of Dementia?

By June 22, 2017

The data indicated continuous PPI use was tied to a reduced risk of cognitive function decline vs. never use (hazard ratio [HR] 0.78, 95% CI: 0.66-0.93; P=0.005).

NAMS: New Position Statement on Hormone Therapy

By June 20, 2017

Firstly, NAMS reiterates that HT should be individualized for each patient and requires periodic reevaluation for risks and benefits of selected therapy.

FDA Fast Tracks Drug for Hallucinations Disorder in Lewy Body Dementia

By June 19, 2017

Nelotanserin is a novel once-daily oral 5HT2A inverse agonist. The 5HT2A receptor has been associated with neuropsychiatric effects, including visual hallucinations.